A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells
- PMID: 15198663
- DOI: 10.1111/j.1471-4159.2004.02456.x
A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells
Abstract
Accumulation of ubiquitinated proteins in inclusions is common to various neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis, although it occurs in selective neurons in each disease. The mechanisms generating such abnormal aggregates and their role in neurodegeneration remain unclear. Inclusions appear in familial and non-familial cases of neurodegenerative disorders, suggesting that factors other than particular mutations contribute to protein accumulation and aggregation. Proteasome impairment triggered by aging or conditions such as oxidative stress may contribute to protein accumulation and aggregation in neurodegeneration. To test this hypothesis in mouse neuronal cells, we overexpressed a 20S proteasome beta5 subunit with an active site mutation. The N-terminal threonine to alanine substitution resulted in impairment of the chymotrypsin-like activity, which is a rate-limiting step in protein degradation by the proteasome. The Thr1Ala mutation was not lethal under homeostatic conditions. However, this single amino acid substitution significantly hypersensitized the cells to oxidative stress, triggering not only the accumulation and aggregation of ubiquitinated proteins, including synuclein, but also cell death. Our results demonstrate that this genetic manipulation of proteasome activity involving a single amino acid substitution causes the formation of protein aggregates in stressed neuronal cells independently of the occurrence of mutations in other cellular proteins. These results support the notion that proteasome disruption may be central to the development of familial as well as sporadic cases of neurodegeneration.
Similar articles
-
Proteasome inhibition in neuronal cells induces a proinflammatory response manifested by upregulation of cyclooxygenase-2, its accumulation as ubiquitin conjugates, and production of the prostaglandin PGE(2).Arch Biochem Biophys. 2000 Feb 15;374(2):325-33. doi: 10.1006/abbi.1999.1646. Arch Biochem Biophys. 2000. PMID: 10666314
-
Ubiquitin proteasome system as a pharmacological target in neurodegeneration.Expert Rev Neurother. 2006 Sep;6(9):1337-47. doi: 10.1586/14737175.6.9.1337. Expert Rev Neurother. 2006. PMID: 17009921 Review.
-
UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.J Neurochem. 2004 Jul;90(2):379-91. doi: 10.1111/j.1471-4159.2004.02485.x. J Neurochem. 2004. PMID: 15228595
-
Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.Hum Mol Genet. 2003 Oct 15;12(20):2609-23. doi: 10.1093/hmg/ddg293. Epub 2003 Aug 27. Hum Mol Genet. 2003. PMID: 12944420
-
The nuclear proteasome and the degradation of oxidatively damaged proteins.Amino Acids. 2007;32(4):527-34. doi: 10.1007/s00726-006-0428-5. Epub 2006 Nov 15. Amino Acids. 2007. PMID: 17103119 Review.
Cited by
-
Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.Biochim Biophys Acta. 2011 Feb;1809(2):128-40. doi: 10.1016/j.bbagrm.2010.07.006. Epub 2010 Aug 3. Biochim Biophys Acta. 2011. PMID: 20674814 Free PMC article. Review.
-
The ubiquitin-proteasome system in spongiform degenerative disorders.Biochim Biophys Acta. 2008 Dec;1782(12):700-12. doi: 10.1016/j.bbadis.2008.08.006. Epub 2008 Aug 23. Biochim Biophys Acta. 2008. PMID: 18790052 Free PMC article. Review.
-
The heavy metal cadmium induces valosin-containing protein (VCP)-mediated aggresome formation.Toxicol Appl Pharmacol. 2008 May 1;228(3):351-63. doi: 10.1016/j.taap.2007.12.026. Epub 2008 Jan 8. Toxicol Appl Pharmacol. 2008. PMID: 18261755 Free PMC article.
-
Ubiquitin-Proteasome System in Neurodegenerative Disorders.J Drug Metab Toxicol. 2015;6(4):187. doi: 10.4172/2157-7609.1000187. Epub 2015 Aug 13. J Drug Metab Toxicol. 2015. PMID: 30761219 Free PMC article.
-
CaMKII is involved in cadmium activation of MAPK and mTOR pathways leading to neuronal cell death.J Neurochem. 2011 Dec;119(5):1108-18. doi: 10.1111/j.1471-4159.2011.07493.x. Epub 2011 Oct 20. J Neurochem. 2011. PMID: 21933187 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases